Soleus Capital Management’s Lyra Therapeutics LYRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-11,848
| Closed | -$2.32M | – | 93 |
|
|
2023
Q3 | $2.32M | Hold |
11,848
| – | – | 0.21% | 67 |
|
|
2023
Q2 | $2.43M | Hold |
11,848
| – | – | 0.27% | 68 |
|
|
2023
Q1 | $1.19M | Hold |
11,848
| – | – | 0.12% | 70 |
|
|
2022
Q4 | $1.86M | Hold |
11,848
| – | – | 0.27% | 61 |
|
|
2022
Q3 | $2.97M | Hold |
11,848
| – | – | 0.4% | 53 |
|
|
2022
Q2 | $3.35M | Buy |
+11,848
| New | +$3.35M | 0.52% | 52 |
|
|
2022
Q1 | – | Sell |
-200
| Closed | -$44K | – | 76 |
|
|
2021
Q4 | $44K | Sell |
200
-4,112
| -95% | -$905K | ﹤0.01% | 66 |
|
|
2021
Q3 | $1.97M | Buy |
4,312
+650
| +18% | +$297K | 0.31% | 59 |
|
|
2021
Q2 | $1.47M | Sell |
3,662
-5,854
| -62% | -$2.35M | 0.23% | 57 |
|
|
2021
Q1 | $5.52M | Buy |
9,516
+393
| +4% | +$228K | 0.99% | 19 |
|
|
2020
Q4 | $5.2M | Buy |
9,123
+6,910
| +312% | +$3.94M | 0.69% | 18 |
|
|
2020
Q3 | $1.24M | Buy |
2,213
+1,000
| +82% | +$559K | 0.66% | 39 |
|
|
2020
Q2 | $687K | Buy |
+1,213
| New | +$687K | 0.39% | 48 |
|